Philips (NYSE:PHG) today agreed to pay approximately $4.2 million to resolve allegations of substituting key components of a monitoring device. The company settled with the U.S. Department of Justice over claims that it substituted the components of its Intellivue MP2 mobile patient monitoring device that it sold to military purchasers without rectifying the device for […]
Patient Monitoring
Study shows workplace productivity improvements with One Drop type 2 diabetes tech
One Drop today announced positive results from a trial of its digital health platform for people with type 2 diabetes. Employees using the One Drop digital diabetes management platform experienced significant productivity and functioning gains and were less likely to experience presenteeism at follow-up compared to control groups. Get the full story at our sister site, […]
Fitbit unveils fall lineup that includes AFib-detecting smartwatch
Google’s Fitbit has announced its upcoming releases this fall, with one health-focused offering providing heart health tracking capabilities. According to a blog post presenting the new offerings, the new Inspire 3, Versa 4 and Sense 2 — the latter of which being the heart health tracker — are all thinner and more comfortable than previous […]
Integra Lifesciences voluntarily recalls CereLink intracranial pressure monitors
Integra LifeSciences (Nasdaq:IART) announced today that it initiated an immediate, voluntary global product removal of CereLink. The company on Aug. 18, 2022, initiated the product removal of all CereLink intracranial pressure monitors as a result of customer reports about monitors whose pressure readings were out of range. According to a news release, Integra believes that […]
Glytec, CPS collaborate on glycemic management support for pharmacy departments
Glytec announced today that CPS Solutions selected it to serve as an insulin management technology resource. Waltham, Massachusetts-based Glytec will serve as a resource for CPS’ more than 2,200 pharmacy professionals across more than 800 healthcare facilities nationwide. Get the full story at our sister site, Drug Delivery Business News.
Hygieia appoints diabetes veteran Doug Lawrence as CEO
Hygieia — a developer of digital therapeutics for insulin therapy — announced today that it appointed Doug Lawrence as its CEO. Lawrence will take the corner office at Livonia, Michigan-based Hygieia with responsibilities for leading operations, development, and global growth of the company and its d-Nav insulin management program. The FDA-cleared d-Nav system autonomously adjusts insulin dose […]
FDA clears Insulet Omnipod 5 for children two years and older
Insulet (Nasdaq:PODD) announced today that the FDA cleared its Omnipod 5 for individuals aged two years and older with type 1 diabetes. Acton, Massachusetts-based Insulet’s Omnipod 5 became the first tubeless, wearable automated insulin delivery system cleared for marketing in the U.S. in January. That clearance covered individuals six years of age and older. In June, the company […]
Tandem Diabetes Care delivers 1 million insulin boluses using t:connect mobile app
Tandem Diabetes Care (Nasdaq:TNDM) announced today that its users have delivered more than 1 million insulin boluses using its app. Users of the t:connect app feature on their mobile devices have reached the 1 million insulin bolus milestone with the t:slim X2 insulin pump within the first month following its commercial release. San Diego-based Tandem designed […]
Verily’s Onduo, Sword Health collaborate on virtual care
Onduo announced today that it entered into a strategic collaboration with Sword Health to broaden virtual care for diabetes and other conditions. Sword Health, a digital musculoskeletal (MSK) care provider, will work with Onduo by Verily, an Alphabet sister company of Google. The idea is to offer complementary solutions, broadening access to virtual care benefits for […]
HeartBeam submits heart attack diagnostic platform for FDA 510(k) clearance
HeartBeam (Nasdaq:BEAT) announced today that it submitted a 510(k) clearance application to the FDA for its HeartBeam AIMI platform. Santa Clara, California-based HeartBeam designed its proprietary electrocardiogram (ECG) technology for use in diagnosing heart attacks. The company’s HeartBeam AIMI platform assists healthcare professionals in identifying patients who present with chest pain to facilitate rapid detection […]
Masimo beats Street in Q2 as healthcare business catches up
Masimo (Nasdaq: MASI) posted second-quarter results today that beat the consensus forecast on Wall Street. The Irvine, California-based patient monitoring tech company reported profits of $18.1 million, or $0.33 per diluted share, on sales of $565.3 million for the three months ended July 2, 2022, for a bottom-line decrease of 64% and sales growth of […]